MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41375-024-02142-9

Медицинская библиотека · Leukemia · 2024

State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia.

Frankhouser David E, Rockne Russell C, Uechi Lisa, Zhao Dandan, Branciamore Sergio, O'Meally Denis, Irizarry Jihyun, Ghoda Lucy, Ali Haris, Trent Jeffery M, Forman Stephen, Fu Yu-Hsuan, Kuo Ya-Huei, Zhang Bin, Marcucci Guido

СтатьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

Chronic myeloid leukemia (CML) is initiated and maintained by BCR::ABL which is clinically targeted using tyrosine kinase inhibitors (TKIs). TKIs can induce long-term remission but are also not curative. Thus, CML is an ideal system to test our hypothesis that transcriptome-based state-transition models accurately predict cancer evolution and treatment response. We collected time-sequential blood samples from tetracycline-off (Tet-Off) BCR::ABL-inducible transgenic mice and wild-type controls. From the transcriptome, we constructed a CML state-space and a three-well leukemogenic potential landscape. The potential's stable critical points defined observable disease states. Early states were characterized by anti-CML genes opposing leukemia; late states were characterized by pro-CML genes. Genes with expression patterns shaped similarly to the potential landscape were identified as drivers of disease transition. Re-introduction of tetracycline to silence the BCR::ABL gene returned diseased mice transcriptomes to a near healthy state, without reaching it, suggesting parts of the transition are irreversible. TKI only reverted the transcriptome to an intermediate disease state, without approaching a state of health; disease relapse occurred soon after treatment. Using only the earliest time-point as initial conditions, our state-transition models accurately predicted both disease progression and treatment response, supporting this as a potentially valuable approach to time clinical intervention, before phenotypic changes become detectable.

Для цитирования: Frankhouser David E, Rockne Russell C, Uechi Lisa, Zhao Dandan, Branciamore Sergio, O'Meally Denis, Irizarry Jihyun, Ghoda Lucy, Ali Haris, Trent Jeffery M, Forman Stephen, Fu Yu-Hsuan, Kuo Ya-Huei, Zhang Bin, Marcucci Guido. State-transition modeling of blood transcriptome predicts disease evolution and treatment response in chronic myeloid leukemia.. Leukemia. 2024. DOI: 10.1038/s41375-024-02142-9.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.